| Focus | Highlights | Research Grants | Awards | Facilities| Careers |
-
Target-specific gastro-intestinal delivery of nano-nutraceuticals and nano-modulating systems for reducing absorption of unwanted substances – A sustainable approach (NTU-Harvard/2017) - Ongoing
-
Responsive nasogastric tubes for confident intubation (MOE POC/2017) - Ongoing
-
Microbial-modifying molecules that enhance wastewater remediation (MOE/2016) - Ongoing
-
Dual‐chemotherapeutic drug delivery systems – pharmacokinetics and pharmacodynamics validation (SPARK/2016) - Ongoing
-
Controlled release polypharmacy system for parkinson's disease management (NTU-NHG/ 2014) - Ongoing
-
Bringing novel biomarkers and technologies closer to clinical application (NHG/2013)
-
Understanding the social, environmental and health impact of nanomaterials (NTU/2013)
-
Developing paclitaxel-loaded poly(lactic-co-glycolic acid) (PLGA) particles as a treatment modality in breast cancer (NMRC/2013)
-
Artificial molecular wires/nanowires for enhancing bioelectronic performance (MOE-Tier 2/2013
-
Development of novel remote bioelectrochemical detectors (BED) for sustainable water infrastructure (SEO/2013)
-
Enhancing microbial redox metabolism for reductive transformations using TETMs (SCELSE/2012
-
Conceptual design of the gastric band (SPRING/2011)
-
TiO2 nanomaterials cause endothelial cell leakiness (MOE-Tier 1/2011)
-
Development of sustained release ganciclovir implant for treatment of CMV retinitis in HIV-AIDS patients (NTU-NHG/2011)
-
Drug-Eluting Balloons (DEB) – Controlled delivery through nanoparticulate coating (NTU-NITHM/2011
-
Drug loaded microparticles encapsulated into bioadhesive films, locally delivered by angioplasty balloons (NRF POC/2011)
-
Drug-releasing bioactive materials and adipose stem cells as autologous scaffolds for bone tissue engineering (A*STAR/2011)
-
Effect of topical application of encapsulated PPARbeta/delta agonist GW501516 microparticles, with two release kinetics, on cutaneous wound healing in diabetic mice – a preclinical animal study (NMRC/2011
-
Bone-targeting nanomedicine for treating osteomyelitis (NMRC/2009)
-
Biodegradable cardiovascular implants: drug-eluting balloons (NRF/2008)
-
Stealth hydroxyapatite nanoparticle for targeted delivery and bioimaging (MOE-Tier1/2007)
Updated on 10 January 2018 | Copyright @ Delivery and Controlled Released Technologies Laboratory, School of Materials Science and Engineering, Nanyang Technological University |